MiR-30a upregulates BCL2A1, IER3 and cyclin D2 expression by targeting FOXL2 - Test2 - elhamkhani - TriplyDB

MiR-30a upregulates BCL2A1, IER3 and cyclin D2 expression by targeting FOXL2

MiR-30a upregulates BCL2A1, IER3 and cyclin D2 expression by targeting FOXL2

http://www.wikidata.org/entity/Q34993681

about

New Concepts in Cancer Biomarkers: Circulating miRNAs in Liquid Biopsies Changes of Microrna Levels in Plasma of Patients with Rectal Cancer during Chemoradiotherapy.Low expression of microRNA-204 (miR-204) is associated with poor clinical outcome of acute myeloid leukemia (AML) patients.Circulating microRNAs in follicular fluid, powerful tools to explore in vitro fertilization process Overexpression of miR-30a in lung adenocarcinoma A549 cell line inhibits migration and invasion via targeting EYA2 MiR-30a regulates the proliferation, migration, and invasion of human osteosarcoma by targeting Runx2.miRNA expression profiling in formalin-fixed paraffin-embedded endometriosis and ovarian cancer samples.miR-30 Family: A Promising Regulator in Development and Disease.MiR-30a: A Novel Biomarker and Potential Therapeutic Target for Cancer

P2860

Q26748881-99A57FDC-E132-4E69-827B-51BCDBBCA929 Q33838484-3FCBF506-5B44-4F7D-9F18-4D671E9C7E0B Q35869716-E6D8C818-3B15-43C6-9AE3-848AD2964E63 Q36824056-465E4604-7A16-4EBD-B4D2-6A09255A4C90 Q36947128-4857FE84-D49B-469C-BE5F-E56FB47E5AE2 Q38829378-9745DA81-60E2-4F38-B4FA-29E187DAB556 Q48000348-FBF15EFB-6B7E-458B-BDCD-F583010B36B7 Q55555002-374AE700-00F9-4F44-98B3-10A81CDEAE5B Q58798691-975CE66C-7A21-4374-A26D-C7DF6E7725E7

P2860

MiR-30a upregulates BCL2A1, IER3 and cyclin D2 expression by targeting FOXL2

http://www.wikidata.org/entity/Q34993681

description

2014 nî lūn-bûn

@nan

2014 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

MiR-30a upregulates BCL2A1, IER3 and cyclin D2 expression by targeting FOXL2

@ast

MiR-30a upregulates BCL2A1, IER3 and cyclin D2 expression by targeting FOXL2

@en

MiR-30a upregulates BCL2A1, IER3 and cyclin D2 expression by targeting FOXL2

@nl

type

label

MiR-30a upregulates BCL2A1, IER3 and cyclin D2 expression by targeting FOXL2

@ast

MiR-30a upregulates BCL2A1, IER3 and cyclin D2 expression by targeting FOXL2

@en

MiR-30a upregulates BCL2A1, IER3 and cyclin D2 expression by targeting FOXL2

@nl

prefLabel

MiR-30a upregulates BCL2A1, IER3 and cyclin D2 expression by targeting FOXL2

@ast

MiR-30a upregulates BCL2A1, IER3 and cyclin D2 expression by targeting FOXL2

@en

MiR-30a upregulates BCL2A1, IER3 and cyclin D2 expression by targeting FOXL2

@nl

P1433

Q34993681-F368EF9C-22E6-4E5B-87D3-4445545338D7

P1476

Q34993681-DEF8D105-0169-470C-8005-3140F6FCF003

P2093

Q34993681-33589A8F-62B2-4203-A180-7DC514F83875

Q34993681-55BAD10F-9A71-4419-A4D8-136C410F9BB5

Q34993681-9281C5C5-4718-404E-8FA5-67DAE62A5B75

P2860

Q34993681-1C6555FF-845F-4183-B946-CCA1F1E5FEC6

Q34993681-1F6F2F8F-395F-4087-9AED-31BFA78B781D

Q34993681-348B4F98-0282-4103-8072-77810CFBE2DE

Q34993681-5390B45D-BA8B-4D09-ABDB-2DAB711A39A1

Q34993681-669B6978-5D95-496F-A371-AD94DA688DA2

Q34993681-76A6ED3B-DFA9-4EC5-A0E8-00E046D3921E

Q34993681-7B9722BB-D73F-44C3-96E4-8F3ED14595F1

Q34993681-8E318DCC-96B7-4B0D-A420-22D020876D3C

Q34993681-A5AE8DCB-7809-463A-8B35-C293B02700AE

Q34993681-B0D4D7F5-8C26-4561-A446-57326B997CD8

P304

Q34993681-86E3255E-0132-40A9-907C-50580AD0F78D

P31

Q34993681-11BA440C-969E-43B8-AA2F-009B58F42E12

P356

Q34993681-3F36A0A1-9204-4838-B6C4-75D6B3EABA83

P433

Q34993681-510083AA-6A4F-4B68-91D8-4673A35AC25B

P478

Q34993681-8BE01034-8EB3-4E14-A1B8-C3389AA972D0

P577

Q34993681-F39C5FAA-1101-4AB7-A95A-44D2AB7ACCA1

P5875

Q34993681-0D71A5CC-266E-45B2-9313-0C37107887BD

P698

Q34993681-ED1302D4-F155-4E72-A353-579935AC89A3

P932

Q34993681-E7CD13DC-B8BA-4183-B4C1-0956522E71E7

P356

P1433

Oncology Letters

P1476

MiR-30a upregulates BCL2A1, IER3 and cyclin D2 expression by targeting FOXL2

@en

P2093

Fei Li

http://www.w3.org/2001/XMLSchema#string

Shengjian Tang

http://www.w3.org/2001/XMLSchema#string

Tairen Wang

http://www.w3.org/2001/XMLSchema#string

P2860

IEX-1L, an apoptosis inhibitor involved in NF-kappaB-mediated cell survival

FOXL2 and BPES: mutational hotspots, phenotypic variability, and revision of the genotype-phenotype correlation

MicroRNA: Implications for Alzheimer Disease and other Human CNS Disorders

Most mammalian mRNAs are conserved targets of microRNAs

Spectrum of FOXL2 gene mutations in blepharophimosis-ptosis-epicanthus inversus (BPES) families demonstrates a genotype--phenotype correlation

FOXL2 inactivation by a translocation 171 kb away: analysis of 500 kb of chromosome 3 for candidate long-range regulatory sequences

Human forkhead L2 represses key genes in granulosa cell differentiation including aromatase, P450scc, and cyclin D2

LATS1 phosphorylates forkhead L2 and regulates its transcriptional activity.

MicroRNAs in human cancer.

The blepharophimosis, ptosis, and epicanthus inversus syndrome: delineation of two types.

P304

967-971

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3892/OL.2014.2723

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

9

http://www.w3.org/2001/XMLSchema#string

P577

2014-11-20T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

271535246

http://www.w3.org/2001/XMLSchema#string

P698

25621074

http://www.w3.org/2001/XMLSchema#string

P932

4301489

http://www.w3.org/2001/XMLSchema#string